CVS Stock Looks Mildly Undervalued Amid Aetna ACA Exit Risks
Market valuation analysis suggests CVS Health shares trade mildly below a fair-value benchmark, with P/E implying a modest discount rather than a clear bargain. Investors weigh fresh headlines that Aetna plans to exit several Affordable Care Act exchanges, alongside CVS’s past sizeable legal penalties, to judge whether potential profitability shifts outweigh ongoing legal and policy risks.